EXCLUSIVE: Brits back sharing DNA for research
The main reason for not sharing DNA for drug research is the fear it could be used without knowledge for corporate gain
Read More
Tag: KPMG
Life sciences leaders welcome UKs industrial strategy
Life sciences leaders have welcomed the government’s new industrial strategy, which gives science and innovation a prominent role in plans for post-Brexit Britain.
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
